{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:56:54Z","timestamp":1761674214423},"reference-count":6,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,10,13]],"date-time":"2013-10-13T00:00:00Z","timestamp":1381622400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Med Imag Rad Onc"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The use of fiducial markers (<jats:styled-content style=\"fixed-case\">FM<\/jats:styled-content>) in image\u2010guided radiotherapy (<jats:styled-content style=\"fixed-case\">IGRT<\/jats:styled-content>) to increase treatment precision is emerging for upper gastrointestinal malignancies. To our knowledge there is no data beyond technical reports for the use of <jats:styled-content style=\"fixed-case\">FMs<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">IGRT<\/jats:styled-content> for gastric cancers in the current literature. We report a case of an 89\u2010year old gentleman with localised gastric cancer who was deemed unfit for surgery and chemotherapy. He had <jats:styled-content style=\"fixed-case\">FMs<\/jats:styled-content> inserted endoscopically around the tumour via ultrasound guidance and received radiotherapy with a high\u2010dose palliative intent via a two\u2010phase technique to 54\u2009<jats:styled-content style=\"fixed-case\">Gy<\/jats:styled-content> in 30 fractions with <jats:styled-content style=\"fixed-case\">IGRT<\/jats:styled-content>. The use of <jats:styled-content style=\"fixed-case\">FMs<\/jats:styled-content> allowed confidence in tumour delineation and together with <jats:styled-content style=\"fixed-case\">IGRT<\/jats:styled-content> enabled precise and safe delivery of a higher dose. The patient tolerated the treatment without significant toxicity and had no evidence of residual or recurrent tumour 12\u2009months following radiotherapy. The use of <jats:styled-content style=\"fixed-case\">FMs<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">IGRT<\/jats:styled-content> in upper gastrointestinal malignancies warrants further collaborative studies.<\/jats:p>","DOI":"10.1111\/1754-9485.12084","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T01:13:45Z","timestamp":1381713225000},"page":"626-628","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The use of fiducial markers in image\u2010guided radiotherapy for gastric cancer"],"prefix":"10.1111","volume":"57","author":[{"given":"Joseph","family":"Sia","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology Austin Health  Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Glance","sequence":"additional","affiliation":[{"name":"Latrobe University Medical Centre  Bundoora Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujievvan","family":"Chandran","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Austin Health  Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhys","family":"Vaughan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Austin Health  Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Austin Health  Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,13]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2007.03.420"},{"key":"e_1_2_3_3_1","unstructured":"ICRU.ICRU report 62: prescribing recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda MD;1999."},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2010.01.003"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.01.006"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-006-0633-y"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00076-2"}],"container-title":["Journal of Medical Imaging and Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1754-9485.12084","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1754-9485.12084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:38:41Z","timestamp":1696221521000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1754-9485.12084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1111\/1754-9485.12084"],"URL":"https:\/\/doi.org\/10.1111\/1754-9485.12084","archive":["Portico"],"relation":{},"ISSN":["1754-9477","1754-9485"],"issn-type":[{"value":"1754-9477","type":"print"},{"value":"1754-9485","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"2013-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-10-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}